Skip to main content
Fig. 3 | BMC Complementary Medicine and Therapies

Fig. 3

From: Qin Huang formula enhances the effect of Adriamycin in B-cell lymphoma via increasing tumor infiltrating lymphocytes by targeting toll-like receptor signaling pathway

Fig. 3

QHF + ADM significantly inhibits the growth of A20 in the tumor-bearing mice model. A. Scheme of the animal experiment protocol. B. Photographs of all the tumor blocks collected from the Control group (n = 5), ADM group (n = 6), and QHF + ADM group (n = 5). C. Tumor volume of the tumor blocks collected from mice on day 12. It showed that QHF + ADM group (n = 5) significantly lowered tumor volume when compared with the control group (n = 5, p < 0.05). But there is no significance between the ADM group (n = 6, p > 0.05) and the control group (n = 5, p > 0.05). D. The tumor volume changes with time of the three groups. The tumor growth of the QHF + ADM group (n = 5) was the slowest of the three groups, followed by the ADM group (n = 5). E. Tumor growth inhibition rate (TGI, %) of the treatment groups. It showed that QHF + ADM (n = 5) could significantly inhibit tumor growth in an A20 murine model (vs. ADM (n = 5), p < 0.01). Data are presented as the mean ± standard errors, *p < 0.05

Back to article page